Your search history is turned on.
Date: May 8, 2024 Jurisdictions: Alberta, British Columbia, Ontario
{E0712532.DOC; 1}. 1101-1030 West Georgia Street Vancouver, British Columbia, Canada, V6E 2Y3 Tel: (780) 466-1481 Fax: (780) 485-1490 E-mail: [email protected] www.bioneutra.ca BIONEUTRA GLOBAL CORPORATIONS SUBSIDIARY BIONEUTRA NORTH AMERICA INC SIGNS AGREEMENT WITH PROTEIN INDUSTRIES CANADA AND PARTNERS Vancouver, British Columbia (May ...
Date: April 26, 2024 Jurisdictions: Alberta, British Columbia, Ontario
Form 52-109FV1 CEITIFICATE OF ANNUAL FILLINGS VENTURE ISSUER BASIC CERTIFICATE I, Yiyuan Jiang, Chief Financial Officer of BioNeutra Global Corporation, certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and information that are incorporated by reference in th...
Form 52-109FV1 CEITIFICATE OF ANNUAL FILLINGS VENTURE ISSUER BASIC CERTIFICATE I, Jianhua Zhu, Chief Executive Officer of BioNeutra Global Corporation, certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and information that are incorporated by reference in the...
BioNeutra Global Corporation TSXV:BGA OTCPINK:BGACF MANAGEMENTS DISCUSSION AND ANALYSIS For the years ended December 31, 2023 and 2022 MANAGEMENTS...
Date: April 26, 2024 Jurisdictions: Alberta, Ontario
Create participation fee form FORM 13-502F1 CLASS 1 AND CLASS 3B REPORTING ISSUERS PARTICIPATION FEE MANAGEMENT CERTIFICATION I, JIANG, Yiyuan, an officer of the reporting issuer noted below have examined this Form 13-502F1 (the Form) being submitted hereunder to the Ontario Securities Commission and certify that to my knowledge, having exercised reasonable...
Create participation fee form Note: [01 Mar 2017] The following is a consolidation of 13-501F1. It incorporates amendments to this document that came into effect on March 1, 2017. This consolidation is provided for your convenience and should not be relied on as authoritative. FORM 13-501F1 CLASS 1 REPORTING ISSUERS AND CLASS 3B REPORTING ISSUERS PARTICIPATI...
BIONEUTRA GLOBAL CORPORATION Consolidated Financial Statements Years Ended December 31, 2023 and 2022 (Expressed in Canadian Dollars) Independent Auditors Report To: The Shareholders of BioNeutra Global Co...
Date: March 21, 2024 Jurisdictions: Alberta, British Columbia, Ontario
{E0716378.DOC; 1} 1101-1030 West Georgia Street, Vancouver British Columbia, Canada, V6E 2Y3 Tel: (780) 466-1481 Fax: (780) 485-1490 E-mail: [email protected] www.bioneutra.ca BIONEUTRA GLOBAL CORPORATION ENGAGES WITH SSC ADVISORY (HONG KONG) LIMITED TO PROVIDE FINANCIAL ADVISORY AND PROJECT MANAGEMENT SERVICES Vancouver, British Columbia (...
Date: February 7, 2024 Jurisdictions: Alberta, British Columbia, Ontario
Microsoft Word - Press Release announcing Stephen Jakeway as officer - Chief Operating Officer - BioNeutra Global Corporation (E0647924x7ADBE) {E0647924.XML; 1} 1101-1030 West Georgia Street, Vancouver British Columbia, Canada, V6E 2Y3 Tel: (780) 466-1481 Fax: (780) 485-1490 E-mail: [email protected] www.bioneutra.ca BIONEUTRA GLOBAL CORPORATION...
Date: November 24, 2023 Jurisdictions: Alberta, British Columbia, Ontario
Officers' Certificate - Q1 - March 31, 2020 (CFO) - BioNeutra (E8690827).DOC FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Yiyuan Jiang, Interim Chief Financial Officer of BioNeutra Global Corporation, certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (to...